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Abstract According to recent observations, there is
worldwide vitamin D insufficiency (VDI) in various pop-
ulations. A number of observations suggest a link between
low serum levels of vitamin D and higher incidence of
chronic pain. A few case reports have shown a beneficial
effect of vitamin D therapy in patients with headache dis-
orders. Serum vitamin D level shows a strong correlation
with the latitude. Here, we review the literature to delineate
a relation of prevalence rate of headaches with the latitude.
We noted a significant relation between the prevalence of
both tension-type headache and migraine with the latitude.
There was a tendency for headache prevalence to increase
with increasing latitude. The relation was more obvious for
the lifetime prevalence for both migraine and tension-type
headache. One year prevalence for migraine was also
higher at higher latitude. There were limited studies on the
seasonal variation of headache disorders. However, avail-
able data indicate increased frequency of headache attacks
in autumn–winter and least attacks in summer. This profile
of headache matches with the seasonal variations of serum
vitamin D levels. The presence of vitamin D receptor,
1a-hydroxylase and vitamin D-binding protein in the
hypothalamus further suggest a role of vitamin D defi-
ciency in the generation of head pain.
Keywords Vitamin D  Headache  Migraine 
Tension-type headache  Pain  Chronic daily headache 
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Introduction
The prevalence and incidence of headache differ widely
between countries and there is an intriguing geographical
pattern [1]. Several factors can be responsible for the
differences of prevalence between countries, such as meth-
odological differences in the studies, and cultural, environ-
mental, metabolic and genetic factors, etc.
Vitamin D insufficiency (VDI) has emerged as a wide-
spread global public health issue in the recent times.
Rickets and osteomalacia are the most common manifes-
tations of VDI. However, recent observations and hypoth-
eses suggest that VDI may affect almost every system of
the body [2]. A number of observations have suggested an
association between low serum levels of vitamin D and
higher incidence of chronic pain [3]. Anecdotal evidences
suggest that vitamin D may be effective in a few headache
disorders [4–6]. If the prevalence rate of a particular disease
increases with increasing latitude, vitamin D deficiency is
another possibility. The role of vitamin D in the patho-
genesis of a few disorders was purported only when it was
noticed that the prevalence of the disease has some relation
with latitude.
We review the articles reporting a role of vitamin D in
headache disorders. We also review the literature to
delineate a relation of prevalence rate of headaches with
the latitude.
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Review of literature
A number of recent observations, including small ran-
domized controlled trials, suggest a link between low
serum levels of vitamin D and higher incidence of chronic
pain [3]. There is no consensus on the optimal levels of
vitamin D. 25-Hydroxyvitamin D level (25(OH) D) of
more than 30 ng/ml is usually considered as a sufficient
vitamin D level. Vitamin D deficiency is considered when
serum 25 (OH) D level is less than 20 ng/ml. Between 20
and 30 ng/ml of 25 (OH) D levels indicate a VDI state [2].
Observations of vitamin D levels with painful conditions
have been made on musculoskeletal pain of limbs, trunk
and joints. No such study has been done in patients with
headache. There are just a few case reports or observations
suggesting a role of vitamin D in headaches [4–6].
Recently, Turner et al. [7] studied the prevalence of vita-
min D inadequacy (\20 ng/ml) among 267 patients with
chronic pain, including headache (25 patients). The prev-
alence of VDI among these 267 patients was 26%. How-
ever, the details of vitamin D levels in headache patients
were not provided. The first case report on a role of vitamin
D (with calcium supplementation) was probably reported
by Thys-Jacobs [5] in 1994. The author demonstrated the
beneficial effect of vitamin D in two female patients with a
history of menstrually related migraine and premenstrual
syndrome. Both the patients had low serum vitamin D
levels (case 1: less than 5 ng/ml; case 2: 17 ng/ml).
Both patients received vitamin D (1,200–1,600 IU daily)
and calcium (1,200–1,600 mg daily) supplementation.
There was a significant reduction in migraine attacks in
2–3 months. Later on, the same author [6] showed dra-
matic reduction in the frequency and duration of migraine
headaches in another two postmenopausal migraineurs with
vitamin D and calcium supplementation. The serum 25
(OH) D levels in these two patients were 19.8 ng/ml (Case
1) and 15 ng/ml (Case 2). Wheeler [8] studied the serum
vitamin D levels in chronic migraine patients; 14.8% of
patients had levels of B20 ng/ml and another 25.9% of
patients had levels between 20 and 30 ng/ml. Recently,
Prakash and Shah [4] reported eight patients with vitamin
D insufficiency having symptoms of both osteomalacia and
chronic tension-type headache. All patients had vitamin D
levels of B10 ng/ml. Both headache and osteomalacia
responded to vitamin D and calcium supplementation in a
few weeks’ duration. Vitamin D insufficiency constitutes
an unrecognized epidemic in many populations worldwide.
Therefore, the causal association of any disease with
vitamin D insufficiency or deficiency should be judged
cautiously.
If vitamin D is important in the generation of head pain,
the incidence of headache will be higher at higher latitudes.
There is at least one report on the relation of headache
prevalence with latitude. Mitsikostas et al. [9] studied the
prevalence of headache in Greece and noted a correlation
of the frequency of daily headache with latitude. The
prevalence and frequency of daily headache was higher in
the northern regions (higher latitude) than in southern
areas. We further searched the literature for a possible
relation of headache prevalence with the latitude. Search
methods included MEDLINE, review articles and reference
lists of relevant manuscripts. The MEDLINE search was
conducted using the keywords ‘‘headache’’, ‘‘prevalence’’
and ‘‘epidemiology’’. Studies were included if they were:
(1) population based; (2) conducted in the general popu-
lations; (3) reporting lifetime or 1-year prevalence of total
headaches, migrainous headaches and tension headaches;
(4) studies using IHS classification or published after 1988;
(5) studies conducted in a city or small county/provinces or
small countries with a narrow latitudinal range (up to 5).
Articles were excluded if (1) the studies were not con-
ducted on the general population (e.g., among students,
clinic-based studies, in workplaces, only in a limited age
group and only on one gender); (2) studies not describing
the time frame for determination of prevalence rate; (3)
national population survey done in a country with a wide
latitudinal range (more than 5, such as the USA, Canada,
Brazil, Japan, France, Sweden, Germany, Denmark); (4)
studies on rare types of headache disorders.
We looked for a relation of headache prevalence with
latitude. The latitude of the city or country, described
in the manuscript, was determined by ‘‘Google Earth’’.
The mean latitude of the country was used as a reference
for seeking its relation with headache prevalence in small
countries.
Although every effort was taken to include all the rel-
evant data described in literature, it might be possible that
some important data could have been missed. We faced a
few problems in including the studies. There were many
differences in methodology and reporting patterns among
the studies. A few studies explored/reported the same
population on two or more occasions. Time frame for
determining the prevalence rate was not described in a few
observations. Some articles described the prevalence rates
in males and females separately, but failed to give a
combined (male and female together) prevalence rate. On a
few occasions, we calculated the combined prevalence rate.
For calculating the total headache prevalence, we com-
bined the total number of male and female patients (if
number was given in the article) having headache and then
expressed it in percentage (the usual method of determin-
ing headache prevalence). The headache types/subclassifi-
cations were not very clear in some studies (such as
non-migrainous headaches, mixed headaches, etc.). We
excluded such type of studies from the final review to
minimize the confounding factors.
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Both lifetime and 1-year prevalence for the total head-
aches did not show any significant relation with the latitude
(and we did not include total headache prevalence in the
table). However, we noted two studies with very low
prevalence of total headache near equatorial areas. Both
studies did not define the time frame for the headache
prevalence. Gourie-Devi et al. [47] reported prevalence of
various neurological disorders in Bangalore, India (12N).
Their survey recruited 102,557 subjects. Prevalence rate
for headache was only 1.1%. Similarly, the prevalence of
headache was relatively low (4%) in Hong Kong (22N), in
the screening of 7,356 persons [48]. These prevalence rates
are very low even if we consider these two as point
prevalence.
We evaluated further to see the relation of latitude with
the prevalence of tension headache, migraine and chronic
daily headache. We noted a significant relation of lifetime
prevalence of both tension-type headache and migraine
with the latitude (Table 1) (Figs. 1, 2, 3). The lifetime
prevalence for migraine was between 2.6 and 6.9 (six
studies) for the people living in a city or country situated
between 0 and 25 (N or S) of latitude. This rate was 12.5–
26.5 (seven studies) in subjects living beyond 30 (N or S)
of latitude. None of the studies on places above 30 of
Table 1 The prevalence of tension headache and migraine (arranged in ascending order of latitude)







Singapore (Nationwide) Ho et al. (2003) [10] 2,096 1N 13 3
San Pablo del Lago (Ecuador) Cruz et al. (1995) [11] 2,723 1S 2.8 6.9
Mbulu, Manyara, Tanzania (Africa) Winkler et al. (2009) [12, 13] 7,412 3S 7.0 4.3
Gbeˆcon-Hounli, Abomey, Benin (Africa) Houinato et al. (2010) [14] 1,113 7N 3.3
Central Ethiopia Tekle haimont et al. (1995) [15] 15,000 9N 3.0
Ibadan (Nigeria) Osuntokun et al. (1992) [16] 18,954 8N 5.3
Nachingwea (Tanzania) (Africa) Dent et al. (2004) [17] 3,351 10S 5.0
Cuzco (Peru) Jaillord et al. (1997) [18] 3,246 13S 5.3
Pureto Rico Miranda et al. (2003) [19] 1,610 18N 13.5
Hongkong (Nationwide) Cheung (2000) [20] 1,436 22N 26.9 4.7
Eastern province (Thugabah) (Saudi Arabia) Al Rajeh et al. (1997) [21] 22,630 22N 9.5 5
Ad Dakhliyah (Oman) Delu et al. (2002) [22] 1,158 23N 11.2 10.1
Taipei (Taiwan) Wang et al. (2000) [23] 3,377 25N 9.1
Qassim (Saudi Arabia) Abduljabbar et al. (1996) [24] 5,891 25N 3.1 2.6
Porto Alegre (Brazil) Wiehe et al. (2002) [25] 1,174 30S 17.1
Jordan (Nationwide) Alzoubi et al. (2009) [26] 4,836 31N 36.1 7.7
Santiago Chile Lavadose et al. (1997) [27, 28] 1,385 33S 26.9 7.3
Daisen (Japan) Takeshima et al. (2003) [29] 4,795 35N 21.7 6.0
Korea (Nationwide) Roh et al. (1998) [30] 2,500 37N 16.2 22.3
Baltimore, Atlanta, and Philadelphia (USA) Bigal et al. (2006) [31] 30,215 39N 12.5
Maryland (USA) Stewart et al. (1996) [32] 12,328 39N 16.6
Maryland (USA) Schwartz et al. (1998) [33, 34] 13,345 39N 40.5 13.3
Philadelphia (USA) Lipton et al. (2002) [35] 4,376 39N 11.6
Sivas (Turkey) Kececi et al. (2002) [36] 947 39N 12.5
Ederin (Turkey) Celik et al. (2005) [37] 386 41N 20
Tbilisi and Kakheti (Georgia) Katsarava et al. (2009) [38] 1,145 41N 37.5 15.6
Bakar (Croatia) Zivadinov et al. (2001), (2003) [39, 40] 3,794 45N 34.8 19 16.7
Doetinchem & Maastricht (Netherlands) Launer et al. (1999) [41] 6,491 51N 23.2 16.3
Mainland (UK) Steiner et al. (2003) [42] 4,007 52N 14.3
Copenhagen Rasmussen et al. (1991) [43] 740 55N 78 16
Akershus, Hedmark or Oppland (Norway) Russell et al. [2008] [44] 2,177 63N 26.5
Nord-Trundelag (Norway) Hagen et al. (2000) [45] 51,383 63N 12.0
Svalbard Lilleng et al. (2009) [46] 1,029 77N 18.0
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latitude had less than 12.5 lifetime prevalence rate for
migraine. Conversely, the maximum lifetime prevalence
rate for migraine at or below 25 of latitude was 6.9
(among six studies). This observation is important, as it
clearly demonstrates a significant relation of lifetime
prevalence of migraine with the latitude (Fig. 1). Although
there were a limited number of population-based studies on
tension headache, the relation of lifetime prevalence rate
with the latitude was also obvious with tension headache.
Four cities or provinces situated between 1 and 25 (N or
S) had prevalence rates of 2.8–12.9. Conversely, two areas
situated beyond 40N had a prevalence rate of 34.8–78.0.
A total of about 50 publications relevant to 1-year
prevalence were identified. Studies on populations of less
than 1,000 were excluded for the observations. Finally, 22
studies were included for the observations (Table 1). The
relation of 1-year prevalence rate with latitude was not as
strong as that observed with lifetime prevalence rate.
However, there were some suggestions indicating that
prevalence of headache would be higher at higher latitude.
We noted 11 studies relevant to 1-year migraine prevalence
in the cities or provinces situated between 0 and 35 (N or
S). The prevalence rate was 3.0–13.5. Prevalence rate of
more than 10 was noted only in two studies. The maximum
1-year prevalence rate was 13.5 below 35 latitude. There
were 11 studies at latitudes higher than 35. The prevalence
ranged from 11.6 to 22.3%. None of the studies had
prevalence rates less than 10. We found only nine popu-
lation-based studies on tension-type headaches reporting a
1-year prevalence rate. Most of the studies were conducted
on subjects residing between 22 and 41 of latitude. Six of
these studies reported a 1-year prevalence rate of more than
25%. There is only one study outside this range (at 3N)
(Table 1). Because of the limited number of studies, we
could not draw on any conclusion. However, a study done
in Tanzania (3S) [12] on 7,412 person demonstrated a
very low 1-year prevalence rate (7%), and this may further
support a possibility of low prevalence rate at the equato-
rial area (as noted above with lifetime prevalence rate for
tension-type headache). We observed 16 studies on the
1-year prevalence of chronic daily headaches. However,
because of the low prevalence rate, no conclusion or sug-
gestions could be made.
We also tried to look at nationwise surveys of big
countries that described the details of regional prevalence
(especially, details of northern and southern areas).
However, there were only a few studies with details of
regional prevalence. Queiroz et al. [49] did an observa-
tional, cross-sectional population-based study for TTH in
the 26 states of Brazil. They reported regionwise preva-
lence. Brazil is a very big country with a wide range of
latitudes. Therefore, we should be very cautious in inter-
preting the data in relation to the latitudes. Nevertheless,
the prevalence rate in southern Brazil (higher latitude)
(14.1%) was more than two times that of northern Brazil
(6.8%). However, this trend of prevalence was not cor-
roborated in the same population for chronic daily head-
ache. The prevalence of CDH was 6.0% in the south and
10.2% in the north [50].
Serum vitamin D levels vary with the season. It peaks in
the months of May–September. The levels tend to be lower
from November to March [51–53]. If vitamin D has any
association with headache, the prevalence rate of headache
should match with the usual seasonal variation of vitamin
D levels. Sudden weather change is one of the most
important factors for the attacks of headache (especially
migraine). Bright sunlight exposure is another important
factor for precipitating headache attacks [53, 54]. There-
fore, it will be very difficult to comment on actual circ-

































































































































Fig. 3 Relation of 1-year prevalence of migraine with latitude
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Most of the studies on season and headache look for the
effects of weather variables (such as temperature, rain,
humidity, atmospheric changes, etc.) in precipitating
headache attacks [53, 54]. Soriani et al. [54] studied the
seasonal variation of migraine attacks in children and noted
increased frequency of attacks in autumn–winter (espe-
cially November–January) with a minimum frequency in
July. A circannual variation with a peak in January has also
been reported for migraine in adults. [55]. Marrelli et al.
[56] studied the seasonal and meteorological factors in
primary headache disorders. The overall frequency of
headaches was highest during winter and least in summer:
17.9% perceived more headaches in winter, 14.9% in
spring, 11.5% in autumn and 10.6% in summer. Limited
studies on this issue have prevented us from giving any
comments with confidence. However, increased frequency
of attacks in autumn–winter (October–January) and least
attacks in summer indirectly suggest a role for VDI in the
generation of recurrent headaches.
Discussion
The prevalence rates of a number of diseases increase with
increasing latitude, i.e., prevalence rates tended to be very
low near the equator and to increase as one moved toward
the poles. Duration and intensity of sunlight shows a strong
correlation with latitude (hence serum vitamin D level).
The protective effect of vitamin D (or sunlight) in reducing
the risk of cancer mortality rate was first suggested when
Garland and Garland [57] noted that colon cancer mortality
rates were highest in places where populations were
exposed to the least amounts of natural light: major cities
and rural areas in high latitudes. This ecological approach
was used to find the first link between vitamin D insuffi-
ciency (minimal sun exposure) and increased risk for other
carcinomas (breast and ovarian carcinoma) [58]. As the
prevalence rate of headache is probably related with the
latitude, a link between VDI and increased prevalence rate
of headache disorders exist.
Low average income, illiteracy and poor health care
facilities are considered as risk factors for various diseases.
Also, the prevalence rate of headache has been demon-
strated to be higher in the illiterate (or with low education
level) population, population with low income and with
poor healthcare facilities, etc. [59]. Average income, liter-
acy and health-care facilities are poorer across the equator.
Therefore, a high prevalence of headache should be sus-
pected in these areas. However, we noted low prevalence in
these areas. Therefore, we suspect the presence of some
protective factors at the lower latitude areas. As higher
serum vitamin D levels are found in the population living at
a lower latitude, it may be one of the important factors for
the low prevalence. However, our observations (a positive
relation of headache prevalence with latitude) should be
judged very cautiously. At the present, it will be difficult to
determine whether these observations are real or due to
methodological differences in the studies. Genetic predis-
position or racial differences are other factors to be con-
sidered in this discussion, although the prevalence of VDI
also depends on genetic and racial factors [60]. The levels
of vitamin D vary during the year. Therefore, the incidence
or frequency of any disease causally related with VDI will
vary with the timing of the studies. Although lifetime or
1-year prevalence of headache will not be affected much by
the timing of the studies, we should be cautious in inter-
preting such data as recall bias may vary with timing:
people tend to remember their more recent headaches.
Besides latitude and season, many other factors affect the
serum vitamin D levels. People who avoid sunlight, at any
latitude, are at risk of vitamin D deficiency. Dark skin
pigmentation, use of sunscreen, clothing, air pollution, cloud
cover, etc., are other factors that affect the vitamin D status
of a person or the population [2]. However, despite all these
barriers, people may have normal serum vitamin D levels if
they take adequate oral vitamin D, including the use of
over-the-counter prescriptions. The analytical problems in
relation to vitamin D assays are other points to be consid-
ered before deciding a causal association of any disease
with vitamin D deficiency [61]. Therefore, our observations
should be judged very cautiously, as the possibility of many
confounding factors exist.
It is difficult to speculate on the exact role of vitamin D
in the generation of head pain, as the pathogenesis of even
bone and muscle pain in patients with VDI is still being
determined. Recently, the presence of VDR and 1a-
hydroxylase (1a-OHase), the enzyme responsible for the
formation of the active vitamin, have been demonstrated in
many areas of the central nervous system including the
prefrontal cortex, hippocampus, cingulate gyrus, thalamus
and hypothalamus [62]. Eyles et al. [62] studied the dis-
tribution of VDR and 1a-hydroxylase in the brain. The
strongest immunohistochemical staining for both the
receptor and enzyme was noted in the hypothalamus (and
substantia nigra.). Recently, Jirikowski et al. [63] studied
immunostaining for vitamin D-binding protein (DBP) in rat
hypothalamus. DBP was observed in widespread axonal
projections throughout the lateral hypothalamus [63].
The exact functions of this VDR in the various sites of
the brain are yet to be determined. However, the presence
of VDR and 1a-hydroxylase in the areas (especially
hypothalamus) implicated in the pathophysiology of vari-
ous primary headache disorders suggests that VDI may
have a role in the generation (or precipitation) of head pain.
In conclusion, increased incidence of headache preva-
lence at higher latitudes hints at a role of VDI in the
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pathogenesis of headache disorders. Demonstration of
vitamin D receptor, 1a-hydroxylase, and vitamin D-binding
protein in the hypothalamus further supports a role of
vitamin D deficiency in the generation of head pain. We
hope our review will act as a catalyst for a controlled study
to clarify the issue.
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